Skip to content
PICO Portalanswers from OpenAlex

Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients

PaperCitations, authors & open-access status

Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients is a paper indexed in PICO Portal from OpenAlex.

How many citations does Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients have?

PICO Portalcitation count

Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients has 136 citations in the OpenAlex counts PICO Portal stores.

When was Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients published?

PICO Portalyear

Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients has 2018 year in the PICO Portal index.

What is the open-access status of Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients?

PICO Portaloa status

Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients has green oa status in the PICO Portal index.

What is the DOI of Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients?

PICO Portaldoi

The DOI for Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients is on the source record.

What is the PMID of Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients?

PICO Portalpmid

The PMID for Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients is on the source record.

What is the OpenAlex record for Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients?

PICO Portalopenalex

The OpenAlex for Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial